Skip to content

SPRING PHARMACEUTICAL GROUP, INC.: 10-Q filed 2018-02-14

What SPRING PHARMACEUTICAL GROUP, INC. reported in its quarterly report filed 2018-02-14 (fiscal Q3 2018): 34 published measures, 92 facts as tagged in accession 0001096906-18-000105.

This filing

Form
10-Q (quarterly report)
Filed
2018-02-14
Fiscal period
fiscal Q3 2018
Accession
0001096906-18-000105 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All SPRING PHARMACEUTICAL GROUP, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2017-12-31102,880,878USD
At 2017-03-3190,287,026USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2017-12-3198,669,900USD
At 2017-03-3184,878,390USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2017-12-3118,768,536USD
At 2017-03-3110,308,622USD
At 2016-12-319,784,431USD
At 2016-03-317,639,084USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2017-10-01 to 2017-12-312,862,281USD92
2017-04-01 to 2017-12-319,095,525USD275
2016-10-01 to 2016-12-312,588,165USD92
2016-04-01 to 2016-12-316,159,400USD275

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2017-04-01 to 2017-12-312,125,638USD275
2016-04-01 to 2016-12-311,374,790USD275

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2017-10-01 to 2017-12-3117,211,156USD92
2017-04-01 to 2017-12-3148,212,805USD275
2016-10-01 to 2016-12-3114,171,624USD92
2016-04-01 to 2016-12-3135,478,603USD275

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2017-04-01 to 2017-12-31-4,453,916USD275
2016-04-01 to 2016-12-31-4,508,068USD275

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2017-12-3191,884,263USD
At 2017-03-3183,061,604USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2017-10-01 to 2017-12-31954,093USD92
2017-04-01 to 2017-12-313,031,841USD275
2016-10-01 to 2016-12-31849,716USD92
2016-04-01 to 2016-12-312,078,344USD275

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2017-12-3116,501,938USD
At 2017-03-3114,487,135USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2017-10-01 to 2017-12-313,783,998USD92
2017-04-01 to 2017-12-3111,465,596USD275
2016-10-01 to 2016-12-313,426,808USD92
2016-04-01 to 2016-12-318,194,522USD275

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2017-12-3124,691,318USD
At 2017-03-3118,477,966USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2017-12-311,362,562USD
At 2017-03-312,985,545USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2017-12-31209,784USD
At 2017-03-311,134,967USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2017-10-01 to 2017-12-313,004,242USD92
2017-04-01 to 2017-12-317,225,755USD275
2016-10-01 to 2016-12-312,386,693USD92
2016-04-01 to 2016-12-316,002,131USD275

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2017-12-313,442,024USD
At 2017-03-315,483,040USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2017-10-01 to 2017-12-316,788,240USD92
2017-04-01 to 2017-12-3118,691,351USD275
2016-10-01 to 2016-12-315,813,501USD92
2016-04-01 to 2016-12-3114,196,653USD275

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2017-10-01 to 2017-12-31280,229USD92
2017-04-01 to 2017-12-31406,640USD275
2016-10-01 to 2016-12-31279,589USD92
2016-04-01 to 2016-12-31754,485USD275

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2017-12-3129,789,168shares
At 2017-03-3129,789,168shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2017-12-314,322,838USD
At 2017-03-314,322,838USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2017-12-31582,006USD
At 2017-03-31-4,386,845USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2017-12-31101,518,316USD
At 2017-03-3187,301,481USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2017-12-3111,740,353USD
At 2017-03-3112,042,758USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2017-12-31785,582USD
At 2017-03-31900,547USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2017-12-31261,277USD
At 2017-03-31508,521USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2017-10-01 to 2017-12-314,419,291USD92
2017-04-01 to 2017-12-3114,216,835USD275
2016-10-01 to 2016-12-31-508,648USD92
2016-04-01 to 2016-12-31412,280USD275

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2017-10-01 to 2017-12-312,776,412USD92
2017-04-01 to 2017-12-318,822,659USD275
2016-10-01 to 2016-12-312,588,165USD92
2016-04-01 to 2016-12-316,159,400USD275

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2017-10-01 to 2017-12-311,445,469USD92
2017-04-01 to 2017-12-313,222,132USD275
2016-10-01 to 2016-12-311,137,609USD92
2016-04-01 to 2016-12-312,722,468USD275

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2017-10-01 to 2017-12-31336,599USD92
2017-04-01 to 2017-12-31951,711USD275
2016-10-01 to 2016-12-31176,755USD92
2016-04-01 to 2016-12-31534,567USD275

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2017-04-01 to 2017-12-31951,711USD275
2016-04-01 to 2016-12-31534,567USD275

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2017-04-01 to 2017-12-31949,886USD275
2016-04-01 to 2016-12-31830,262USD275

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2017-04-01 to 2017-12-31268,475USD275
2016-04-01 to 2016-12-31-10,893USD275

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

PeriodValueUnitDays
2017-04-01 to 2017-12-313,495,744USD275
2016-04-01 to 2016-12-311,663,060USD275

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2017-04-01 to 2017-12-312,286,222USD275
2016-04-01 to 2016-12-31-1,739,711USD275

Inspect the source

Entity
SPRING PHARMACEUTICAL GROUP, INC. / CIK 0000847464
Captured
SEC response SHA-256
21fd63bfa4a441f5dd22dbcc8093e88a40c5d63950c8b6833c77a7b4245f4dc7

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000847464.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))